ZBTB18 and colorectal cancer: These findings are consistent with the tumor suppressor activity observed when ZBTB18 was overexpressed in colon cancer cells, and indicate that the levels of expression of this transcriptional repressor could be useful to identify a subset of locally advanced colorectal cancer patients with poor prognosis that are good candidates to receive a more aggressive form of treatment and/or closer follow up.